RAHWAY, N.J., June 23, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 HYPERION study evaluating WINREVAIR ...

Interestingly enough, though some lighting experts recommend you not use a standard bulb in a 3-way socket, they generally agree that taking the opposite approach will, more often than not, work ...

By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Business Update First Site Activated for Phase 3 OVATION 3 Trial of IMNN-001 in Ovarian Cancer On May 8, 2025, Imunon, Inc ...

(RTTNews) - Compass Pathways plc (CMPS) announced Monday that its investigational psilocybin therapy, COMP360, met the primary endpoint in the Phase 3 COMP005 trial for treatment-resistant ...

Phase Three consists of the next four weeks of the program. Teams may conduct a total of 10 days of organized team practice activity, or "OTAs". No live contact is permitted, but 7-on-7, 9-on-7 ...

The phase 3 trial enrolled 1033 patients who had not received prior chemotherapy for mCRPC and had evidence of disease progression despite androgen deprivation therapy.

Nearly 3 Years After Her Divorce From Tom Brady, Gisele Bündchen Said She Feels Like She’s “Earned” This New Phase Of Her Life. Ellen Durney. Tue, May 27, 2025 at 1:53 PM UTC.

Management expects to initiate Phase 3 trials for subcutaneous VK2735 in Q2 2025, focusing on obesity and type 2 diabetes ...

Trontinemab 3.6 mg/kg reduced amyloid below 24 centiloids in 81% of participants after 28 weeks, with mild ARIA-E cases in <5% of patients. Roche's Elecsys pTau181 plasma test showed potential to ...

PANOVA-3 is a prospective, randomized, open-label, controlled Phase 3 clinical trial designed to test the efficacy and safety of Tumor Treating Fields (TTFields) therapy used concomitantly with ...

The STOP-HS clinical trial program includes two Phase 3 studies, STOP-HS1 (NCT05620823) and STOP-HS2 (NCT05620836), evaluating the efficacy and safety of povorcitinib (INCB54707) in adult patients ...

In June 2024, SSC selected Blue Origin, SpaceX and United Launch Alliance as initial awardees for the potential 10-year, $5.6 billion NSSL Phase 3 Lane 1 contract to facilitate the deployment of ...